|
'Imi Hale Native Hawaiian Cancer Network
|
3U54CA153459-02S1
|
$47,445
|
$27,993
|
CHONG, CLAYTON
|
PAPA OLA LOKAHI
|
|
'Imi Hale Native Hawaiian Cancer Network
|
3U54CA153459-02S2
|
$45,000
|
$26,550
|
CHONG, CLAYTON
|
PAPA OLA LOKAHI
|
|
'Imi Hale Native Hawaiian Cancer Network
|
5U54CA153459-02
|
$766,516
|
$452,244
|
CHONG, CLAYTON
|
PAPA OLA LOKAHI
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
$161,938
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) University of Guam/University of Hawaii Cancer Center Partnership
|
5U54CA143727-09
|
$1,119,110
|
$55,956
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
|
1R01CA231291-01
|
$533,211
|
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
|
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
|
1R01CA231283-01
|
$501,220
|
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias
|
1R01CA219460-01A1
|
$397,573
|
|
MENDENHALL, ALEXANDER
|
UNIVERSITY OF WASHINGTON
|
|
(PQ11) Dietary strategies to enhance FOLFOX cancer therapies
|
1R21CA231255-01
|
$189,744
|
|
ROSENBERG, DANIEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
|
1R01CA231267-01
|
$460,814
|
|
FEHRENBACHER, JILL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
|
1R01CA231325-01
|
$572,540
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS
|
1R01CA230712-01
|
$633,992
|
|
JENKINS, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models
|
1R01CA230995-01
|
$374,578
|
|
EASWARAN, HARIHARAN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
|
1R01CA231112-01
|
$576,627
|
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
|
1R01CA216101-01A1
|
$670,933
|
|
SHADEL, GERALD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
|
5R01CA220004-02
|
$698,964
|
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
5R01CA208735-02
|
$730,063
|
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
|
1R01CA231295-01
|
$481,288
|
|
OSMAN, IMAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
5R01CA208765-03
|
$343,846
|
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ9)A redox-mediated mechanism of chemotherapy-induced cognitive impairment
|
5R01CA217934-02
|
$463,899
|
|
ST CLAIR, DARET
|
UNIVERSITY OF KENTUCKY
|
|
00005I-716 NCI-DCCPS -- 8481398
|
N02CA100005
|
$1,896,375
|
$1,896,375
|
UNKNOWN, UNKNOWN
|
KELLY SERVICES INC
|
|
1/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202920-02
|
$301,538
|
|
MEADE, CATHY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2 The GUIDE Cancer Research Training Project
|
5P20CA202908-04
|
$186,883
|
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221697-02
|
$310,904
|
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
10th Conference on Health Survey Research Methods
|
1R13CA156961-01
|
$10,000
|
$2,500
|
JOHNSON, TIMOTHY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
$175,125
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/2 Southeast Partnership for Improving Research & Training in Cancer Health Disparities
|
5P20CA202922-02
|
$242,408
|
|
MIELE, LUCIO
|
LSU HEALTH SCIENCES CENTER
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
5P20CA221696-02
|
$222,707
|
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2-Air Pollution and Health GeoHealth Hub Research and Capacity Building-US
|
5U2RTW010108-04
|
$224,999
|
|
CASH, RICHARD
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-13
|
$1,101,004
|
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
2011 Hormone Action In development & Cancer GRC
|
1R13CA159536-01A1
|
$8,000
|
$2,000
|
RUSSO, JOSE
|
GORDON RESEARCH CONFERENCES
|
|
22nd International AIDS Conference (AIDS 2018), Amsterdam, the Netherlands, 23-27 July 2018
|
1R13AI138840-01
|
$10,000
|
|
BEYRER, CHRISTOPHER
|
IAS
|
|
A Biopsychosocial Approach to Behavioral Oncology in Young Adults
|
5F99CA222727-02
|
$32,259
|
|
DARABOS, KATHLEEN
|
HUNTER COLLEGE
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
|
5U01DK108300-04
|
$190,000
|
|
PARK, WALTER
|
STANFORD UNIVERSITY
|
|
A communication-based intervention for advanced cancer patient-caregiver dyads to increase engagement in advance care planning and reduce caregiver burden
|
1R21CA224874-01A1
|
$192,247
|
$192,247
|
SHEN, MEGAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A Conference Grant for Special Programming on Decision Making in Cancer
|
5R13CA142007-03
|
$15,000
|
$15,000
|
HUANG, ELBERT
|
UNIVERSITY OF CHICAGO
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
2U24CA076518-21
|
$990,209
|
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Decision Making Framework for Contralateral Prophylactic Mastectomy
|
5R21CA149803-02
|
$174,540
|
$87,270
|
BREWSTER, ABENAA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC
|
1R21CA229927-01
|
$218,588
|
|
WAJAPEYEE, NARENDRA
|
YALE UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yuan,
|
ZIA CP010121-10349
|
$310,287
|
$155,143
|
Lan, Qing
|
DCEG (NCI)
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
5R01CA122128-04
|
$559,603
|
$559,603
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A Magnetic Bead Assay for Rapid Isolation and Identification of Circulating Tumor Cells
|
1R43CA228917-01
|
$300,000
|
|
LIU, PENG
|
MICROSENSOR LABS, LLC
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
Total relevant funding to Basic Behavioral and Social Science for this search: $97,845,123
|